"How much does the Wegovy pill cost in the UK?" is one of the first questions patients ask when they hear that oral semaglutide is now an option alongside the weekly injection. The honest answer is that there is no single list price — the total depends on your dose, the pharmacy you use, whether you access it through the NHS or privately, and how much monitoring is folded into the plan. This article breaks the cost picture down into the parts you can actually budget for.
What "cost" actually means for the Wegovy pill in the UK
Unlike a supermarket item, a prescription medicine's cost isn't a single number. For the Wegovy pill in UK private practice, three parts stack together: the consultation and any baseline checks, the medication itself month by month, and the ongoing monitoring reviews that a prescribing service builds in as you titrate up. NHS access exists but is narrow and rationed, so for most UK patients the private route is the realistic frame.
Semaglutide is prescription-only in the UK, whether taken as a tablet or as an injection. That legal category means a UK-registered clinician has to assess suitability first, so a pure "medicine only" price rarely exists — reputable private services always bundle in a clinician conversation. If you see a price advertised without a consultation, that is a red flag rather than a saving.
Private prescription — monthly medication cost
In UK private practice, the monthly medication cost for oral semaglutide typically sits in a band around £200 to £300. That range reflects three moving parts: the dose you're currently on (starting doses are lower and often cheaper than maintenance doses), the pack size dispensed, and the pharmacy's own margin. Some services also offer discounted subsequent months if the first month is at a higher tier.
Because the dose is titrated up gradually over the first few months, your monthly cost may change as you step up. Patients who stay on a lower dose for medical or tolerability reasons may sit at the lower end of the band; patients who titrate to the full maintenance dose typically sit at or above the higher end. Our piece on whether there is a Wegovy pill in the UK covers the licensing background if you want the context behind the pricing.
Initial consultation and baseline checks
The first appointment is where a clinician takes a medical history, checks BMI and blood pressure, reviews current medications, and decides whether oral semaglutide is a reasonable fit. In UK private practice this typically costs somewhere in the region of £50 to £150, either charged separately or bundled into the first month of medication. Some services fold a first video review into the medication cost and only charge separately if additional work is needed.
Baseline blood tests aren't always required for oral semaglutide, but a clinician may recommend them if your history flags a reason to check thyroid function, HbA1c, liver function or lipids. If tests are added, private blood panels usually sit in the £40 to £120 range depending on the panel.
Ongoing monitoring cost
A well-run private weight-management plan builds in periodic reviews — commonly at the end of the first month and then every one to three months. Reviews check tolerance, side effects, blood pressure, weight trajectory and dose titration. Some pharmacies include these reviews in the monthly medication price; others charge for them as separate £25 to £75 clinical fees. When comparing offers, it's worth asking exactly what the monthly figure includes rather than comparing headline numbers.
NHS availability and eligibility
NHS access to semaglutide for weight management — whether as the injection or the oral tablet — is limited. Prescribing is routed through specialist tier-3 or tier-4 weight-management services under NICE eligibility criteria, which typically require a BMI above a specified threshold plus a weight-related comorbidity, and often a course of structured weight-management support before pharmacotherapy is offered. Waiting lists to enter these services can be long.
Where NHS access is granted, the direct medication cost to the patient is the standard NHS prescription charge (or free in Scotland, Wales and Northern Ireland). Practically, though, most UK adults searching for an oral Wegovy option today are looking at a private route rather than an NHS one.
How pill and injection costs compare
Patients often assume the tablet must be cheaper than the injection. In reality the two formats sit in broadly similar monthly bands in UK private practice, and neither is reliably cheaper than the other. Pricing for the injectable Wegovy pen also varies by dose strength, pack size and pharmacy. Similarly, Mounjaro (tirzepatide) — a different molecule delivered as a weekly injection — has its own price band that overlaps with semaglutide products. Our comparison of Wegovy pill vs injection covers the practical differences beyond price.
Cost tiers — a UK planning table
These figures are honest planning bands, not fixed prices. Actual costs vary by dose, pack size, pharmacy and how much monitoring is bundled in.
| Cost tier | Typical UK private range | What it usually covers |
|---|---|---|
| Initial consultation & baseline checks | ~£50 – £150 (one-off) | Video or in-person clinician review, BMI/blood pressure, medication history, suitability decision; optional blood tests if flagged |
| Monthly medication | ~£200 – £300 (per month) | Oral semaglutide dispensed for the current dose step; may include a short check-in |
| Ongoing monitoring reviews | ~£0 – £75 per review (often quarterly) | Tolerance check, dose review, weight and blood pressure; may be bundled into the monthly price |
| Estimated 12-month total | ~£2,500 – £3,800+ | Combined consultation, twelve months of medication and periodic reviews; higher if you titrate to full maintenance dose |
Insurance and employer cover
Private medical insurance in the UK rarely covers weight-management medication. Most standard policies exclude drugs used primarily for weight loss, even when a specialist has recommended them. A minority of employer-provided schemes now include structured weight-management support, occasionally covering some of the consultation cost, but medication itself is usually still self-funded. It is worth checking your policy wording rather than assuming either way.
The total 12-month cost picture
Adding the parts together gives a realistic annual budget rather than a headline monthly figure. A patient who has a £100 initial consultation, sits on the lower £200 monthly medication band throughout the year and pays for four £50 monitoring reviews would land somewhere near £2,700. A patient who titrates to a higher dose and pays £280 a month with the same consultation and monitoring pattern would land closer to £3,700. Those are illustrative — the point is to plan for the year, not the month.
A separate but important budget question is what happens if you stop. GLP-1 medications for weight management are typically framed as long-term, so the annual figure is likely to be a recurring cost rather than a one-off, and a clinician will discuss with you what a sustainable plan looks like. Your clinician will advise based on your individual circumstances. For related context on switching or stopping, see our overview page on Weight Management.
What affects your specific cost
Three variables move your number most. Dose: a higher maintenance dose usually costs more per month than the starting dose. Pharmacy: services differ in how they bundle consultation and monitoring, and headline prices are not always comparing the same thing. Continuity: some services offer a slightly lower price for patients who stay on the same product for several consecutive months. A structured consultation is the point at which those variables get honest answers.